Table 2 Associations between clinical risk factors and 60-day cause-specific mortality in continuing care residents in Alberta who were confirmed tested first positive or first negative with a Covid-19 infection between, March 1, 2020, to March 31, 2021.
Characteristic | Univariable | Multivariable | ||
|---|---|---|---|---|
ORs (95% CI) | p-value | AORs (95% CI) | p-value | |
Age | 1.04 (1.03, 1.04) | < 0.01 | 1.05 (1.04, 1.05) | < 0.01 |
Gender | ||||
Male | 1.40 (1.29, 1.52) | < 0.01 | 1.57 (1.42, 1.73) | < 0.01 |
Female | 1 [Reference] | 1 [Reference] | ||
Specimen collection location | ||||
LTC | 1 [Reference] | 1 [Reference] | ||
DSL | 0.42 (0.38, 0.47) | < 0.01 | 0.97 (0.72, 1.30) | 0.82 |
ED | 3.09 (2.61, 3.64) | < 0.01 | 4.54 (3.57, 5.77) | < 0.01 |
H | 2.33 (1.92, 2.82) | < 0.01 | 3.6 (2.76, 4.68) | < 0.01 |
Resident during collection | ||||
LTC | 1 [Reference] | 1 [Reference] | ||
DSL | 0.49 (0.45,0.54) | < 0.01 | 0.54 (0.41, 0.71) | < 0.01 |
Symptomatic during collection | ||||
No | 1 [Reference] | 1 [Reference] | ||
Yes | 2.33 (2.09, 2.61) | < 0.01 | 2.02 (1.77, 2.32) | < 0.01 |
Unknown | 2.02 (1.82, 2.25) | < 0.01 | 1.45 (1.27, 1.65) | < 0.01 |
Result of the covid test | ||||
Negative | 1 [Reference] | 1 [Reference] | ||
Positive | 4.25 (3.89,4.64) | < 0.01 | 3.61 (3.14, 4.15) | < 0.01 |
Specimen year-month collection | ||||
2020-3 (original) | 6.25 (5.17, 7.57) | < 0.01 | 4.62 (3.71, 5.75) | < 0.01 |
2020-4 (alpha) | 4.01 (3.47, 4.64) | < 0.01 | 2.96 (2.52, 3.48) | < 0.01 |
2020-5 | 3.59 (3.04, 4.24) | < 0.01 | 2.08 (1.71, 2.53) | < 0.01 |
2020-6 | 1 [Reference] | 1 [Reference] | ||
2020-7 | 3.56 (2.85, 4.44) | < 0.01 | 2.15 (1.68, 2.76) | < 0.01 |
2020-8 | 2.48 (1.82, 3.37) | < 0.01 | 1.74 (1.24, 2.44) | < 0.01 |
2020-9 | 3.12 (2.33, 4.17) | < 0.01 | 1.71 (1.24, 2.36) | < 0.01 |
2020-10 (delta) | 4.39 (3.65, 5.29) | < 0.01 | 2.15 (1.73, 2.68) | < 0.01 |
2020-11 | 5.40 (4.56, 6.40) | < 0.01 | 2.36 (1.91, 2.90) | < 0.01 |
2020-12 (beta) | 5.55 (4.75, 6.49) | < 0.01 | 2.18 (1.78, 2.68) | < 0.01 |
2021-1 (gamma) | 6.4 (5.30, 7.73) | < 0.01 | 2.03 (1.59, 2.58) | < 0.01 |
2021-2 (theta) | 2.95 (1.99, 4.36) | < 0.01 | 2.04 (1.32, 3.15) | < 0.01 |
2021-3 | 1.86 (1.00, 3.46) | 0.05 | 1.47 (0.72, 3.00) | 0.29 |
Hospital and outpatient | ||||
#H admits 1 year | 1.12 (1.08, 1.16) | < 0.01 | 1.02 (0.97, 1.08) | 0.44 |
#SCU admits 1 year | 1.21 (0.94, 1.55) | 0.13 | 1.15 (0.83, 1.60) | 0.41 |
#DAD proc 1 year | 1.04 (1.01, 1.07) | 0.01 | 1.01 (0.97, 1.06) | 0.59 |
#NACRS proc 1 year | 1.00 (0.99, 1) | 0.47 | 1.00 (1.00, 1.00) | 0.52 |
Comorbidities | ||||
Num of Elixhauser | 1.05 (1.04, 1.07) | < 0.01 | 1.03 (1.01, 1.05) | < 0.01 |
Fluid and electrolyte disorders | 1.47 (1.35, 1.61) | < 0.01 | 1.19 (1.07, 1.34) | < 0.01 |
Diabetes | 1.12 (1.03, 1.23) | 0.01 | 1.11 (1.00, 1.23) | 0.06 |
Metastatic cancer | 1.92 (1.48, 2.5) | 0.00 | 1.58 (1.14, 2.19) | < 0.01 |
Liver disease | 1.24 (0.98, 1.56) | 0.07 | 1.51 (1.15, 1.99) | < 0.01 |
